Regulatory and pharmacological aspects of adverse drug reaction reporting: perspectives on pharmacists' impact and public health roles
- At: 2007 FIP Congress in Beijing (China)
- Type: Presentation
- By: SUBRAMANIAM, Vaiyapuri (U.S. Department of Veterans Affairs, Washington, DC, United States of America)
The proliferation in the use of medicines has increased the risks posed by medication-related adverse drug events (ADE) resulting in adverse drug reactions (ADRs). An increased understanding of ADRs is essential to ensure the safe use of medicines. Access to ADE information from regulatory requirements and voluntary reporting and surveillance.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.